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Abstract
Infectious diseases are common in internationally adopted children (IAC).
With the objective to evaluate infectious diseases prevalence in a large cohort of IAC and to explore possible risk factors for
tuberculosis (TB) and parasitic infections, clinical and laboratory data at first screening visit of all IAC (<18 years) consecutively
referred to our Center in 2009 to 2015 were collected and analyzed.
In total, 1612 children (median age: 5.40 years; interquartile range: 3.00–7.90) were enrolled, 123/1612 (7.60%) having medical
conditions included in the special needs definition. The most frequent cutaneous infections wereMolluscum contagiosum (42/1612;
2.60%) and Tinea capitis (37/1612; 2.30%). Viral hepatitis prevalence was<1% (hepatitis B virus [HBV]: 13 children, 0.80%; hepatitis
C virus: 1 child, 0.10%; hepatitis A virus: 6 children, 0.40%). A parasitic infection was diagnosed in 372/1612 (23.10%) children. No
risk factors for parasitosis were evidenced. Active TBwas diagnosed in 4/1355 (0.3%) children, latent TB in 222/1355 (16.40%). Only
3.7% (51/1355) children had concordant positive tuberculin skin test (TST) and QuantiFERON-TB-Gold In-Tube (QFT-G-IT) results.
Risk factors for TST+/QFT-G-IT results were previous Bacille de Calmette-Guérin vaccination (adjusted odds ratio [aOR]: 2.18;
96% confidence interval [CI]: 1.26–3.79; P=0.006), and age ≥5 years (aOR: 1.49; 95% CI: 1.06–2.11; P=0.02). The proportion of
children with nonprotective titers for vaccine-preventable diseases (VPD) ranged from 15.70% (208/1323) for tetanus to 35.10%
(469/1337) for HBV.
Infectious diseases were commonly observed in our cohort. The high rate of discordant TST/QFT-G results brings up questions
regarding the optimal management of these children, and suggests that, at least in children older than 5 years, only QFT-G-IT results
may be reliable. The low proportion of children protected for VPD, confirms importance of a timely screening.
Abbreviations: BCG = Bacille de Calmette-Guérin, CLIA = chemiluminescent immunoassay, FASD = fetal-alcohol spectrum
disorder, HAV = hepatitis A virus, HBV = hepatitis B virus, HCV = hepatitis C virus, HIV 1–2 = human immunodeficiency virus types I
and II, IAC = internationally adopted children, IGRA = interferon-gamma-release assay, IQR = interquartile range, LTBI = latent
tuberculosis infection, PCR = polymerase chain reaction, QFT-G-IT = QuantiFERON-TB-Gold In-Tube assay, TPHA = Treponema
pallidum hemagglutination assay, TST = tuberculin skin test, VPD = vaccine preventable diseases.
Keywords: adoption, children, infectious diseases, parasitic infection, tuberculosis
1. Introduction
Every year more than 2000 children are internationally adopted
in Italy, which represents the country with the second highest rate
of adoptions after the United States.[1] The living conditions of
these children in their country of origin vary greatly. Most of
them reside in orphanages, where they may experience
malnutrition, emotional and physical neglect, environmental
deprivation, and where they have been susceptible to infectious
diseases such as tuberculosis (TB), chronic viral diseases, and
parasitic infections.[2–9] Moreover, internationally adopted
children (IAC) have often experienced pre- and peri-natal
complications, such as exposure to drugs and alcohol during
gestation, absence of peri-natal care, low birth weight, and
prematurity.[2–9] Although children are declared healthy in their
home countries, medical disorders are often missed or diagnosed
after adoption: medical preadoption information can be incom-
plete, wrongly translated and/or discordant.[2–9] Medical care is
crucial upon the child’s arrival into the country: international
adoption medicine is growing for understanding and addressing
the specific healthcare needs of these children after their
arrival.[10–12] Medical comprehensive evaluations frequently
identify unsuspected medical disorders, infections, as well as
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delayed or incomplete vaccinations: the early identification of
infections and lack of protection toward vaccine preventable
diseases (VPD) makes treatment of potential transmittable
diseases and updating of immunizations possible.[13–21]
The majority of the available studies focus on a single issue in
selected populations,[12,22–28] whereas few studies are available
investigating the prevalence of several pathologies, infectious or
not, and immunization status in large cohorts of IAC.[2,16,29,30]
Each country has a different geographic profile of IAC, thus
medical problems in these children could vary according to their
origin. Most of the literature data come from United States
studies,[3–5,9,14,20–22,24,26,28] and only few reports have investi-
gated the health status of IAC in Europe.[2,10,13,15–19,29,31–36]
Prevalence of medical problems was described in more than 40%
of the cases by van Schaik and colleagues in The Netherlands.[13]
Other authors found a substantially higher risk of hospitalization
or the need for a specialistic consultation in IAC with respect to
not-adopted children.[37] Early pubertal development, chronic
malnutrition and low weight are frequently reported condi-
tions.[32,35] Hénaff and colleagues reported 55% prevalence of
infectious diseases in 133 children adopted in France.[2] Intestinal
parasitic and dermatologic infections have been described as the
most frequent infectious diseases, with an observed prevalence
ranging from 8% to 42.7% and from 22% to 35%, respective-
ly.[2,10,13,16,33,34,36]
In the present study, we evaluated the prevalence of infectious
diseases in a large cohort of IAC referred to a single center in Italy.
Also, we explored possible risk factors for TB and parasitic
infections.
2. Materials and methods
2.1. Study group
All IAC (ages 18 years, originating from any foreign country)
consecutively referred to the Center for the Internationally
Adopted Child of the Infectious Disease Unit (Anna Meyer
Children’s University Hospital, University of Florence, Italy) in a
7-year period (January 2009 to December 2015) underwent the
internal operative protocol for the first screening for IAC and
were prospectively enrolled in the study. The only exclusion
criterion was being adopted from Italy. Medical records were
prospectively collected and entered into an electronic database.
Written informed consent to the study was obtained from all the
parents of the enrolled children. The study was approved by the
Ethics Committee for Human Investigation at the Meyer
Children University Hospital.
2.2. Screening protocol
All the children underwent an internal standard operative
protocol, developed following international recommenda-
tions.[16,38] Social-demographic data collected included age on
arrival in Italy, age at first evaluation, sex, and country of origin.
Family and personal medical history and preadoption immuni-
zation records were reviewed when available. Information about
possible fetal-alcohol spectrum disorder (FASD), presence of
simple or complex malformations, or other clinically relevant
pathologies were also registered. Children were considered
vaccinated with Bacille de Calmette-Guérin (BCG) whether a
clear documentation was available and/or a BCG scar was noted.
All the children were clinically evaluated and pubertal Tanner
stage was recorded, as well as the presence of clinical signs of
pathology. In case of a cutaneous infection suspicion, a
dermatologic evaluation was also performed. At the first
evaluation, all the children underwent a venupuncture and
laboratory assessment including a complete blood count with
differential. Other tests executed included serologic tests for
several infectious diseases, and, in particular, hepatitis B virus
(HBV), hepatitis C virus (HCV), hepatitis A virus (HAV), human
immunodeficiency virus types I and II (HIV 1–2), Treponema
pallidum, and Toxocara canis. Serologic tests to evaluate
vaccination coverage for tetanus, diphtheria, measles, mumps,
and rubella were also performed. Tuberculin skin test (TST) and
QuantiFERON-TB-Gold In-Tube assay (QFT-G-IT) were per-
formed, and a chest radiographwas executed if TST orQFT-G-IT
were positive, according to the international guidelines
definitions.[39–41] Additionally, 3 stool samples were collected
for the search for ova and parasites and for the antigen test for
Giardia lamblia.
2.3. Laboratory tests and TST
All the other laboratory examinations were performed in the
same laboratory at the Meyer Children’s University Hospital,
using standardized techniques and according to manufacturers’
instructions.
Evaluation ofHBV surface antigen andHBV surface antibodies,
serology for HCV (dosage of HCV antibodies, HCV Ab), HAV
(dosage ofHAV IgMand IgG),Tpallidumhemagglutination assay
(TPHA), HIV1–2 antibodies and antigen p24 and serologies for
measles (measles IgG and IgM), and rubella (rubella IgG and IgM)
were performed with chemiluminescent immunoassay (CLIA)
technology (LIAISONXL System, DiaSorin, Saluggia [VC], Italy).
Serologies for mumps (mumps IgG and IgM), tetanus (tetanus
IgG), anddiphtheria (diphtheria IgG)were performedwith specific
enzyme-linked immunosorbent assay (ELISA).
In case of positive serology for HBV or HCV, a polymerase
chain reaction (PCR) was performed, with artus HBV PCR Kits
CE (QIAGEN, Hilden, Germany).
A diagnosis of giardiasis was performed based on stool ova and
parasites examination results on 3 specimens, as previously
described.[23] Stool ova and parasites examination was per-
formedwith Lugol’s staining solution, through direct observation
and 10 and 40 microscopic enhancement.
A diagnosis of toxocariasis was performed by a serologic test
that usesT canis excretory-secretory antigen to detect specific IgG
antibodies by ELISA. When results were uncertain, Western Blot
serology for T canis was performed. If concomitant hyper-
eosinophilia was detected, specific treatment with albendazole
was proposed.
Following the American Academy of Pediatrics guidelines,[39] a
positive TST was defined as an induration size ≥10mm.[39–41]
TST was administered by trained nurses working in our
Infectious Disease Unit and was performed according to the
Mantouxmethod by injecting intradermally 5 tuberculin units (in
0.1mL) of purified protein derivative (Statens Serum Institute,
Copenhagen, Denmark) into the volar surface of the forearm.
The transversed skin induration was recorded (in mm) after 48 to
72h directly by a pediatrician of the Infectious Disease Unit or by
the family physician.
2.4. QuantiFERON-TB-Gold In-Tube
The QFT-G-IT assay (Cellestis Inc., Chadstone, Australia) was
performed according to the manufacturer’s instructions, as
previously described. After subtracting the value from the
Sollai et al. Medicine (2017) 96:12 Medicine
2
negative control, the result was positive if the antigen-dependent
response was ≥0.35 IU, negative if the mitogen-induced response
was ≥0.5 IU/mL and the antigen-dependent response was <0.35
IU/mL, and indeterminate if both mitogen-induced and antigen-
dependent responses were below cut-off or mitogen-induced
response >8IU/mL. A second test was repeated when an
indeterminate result was recorded.
2.5. Tuberculosis definition
Study children were classified as not-infected, latent tuberculosis
infection (LTBI) cases, or active TB disease cases, following the
American Academy Guidelines definition.[39] Asymptomatic
children with negative TST and negative QFT-G-IT were defined
as uninfected. Confirmed LTBI diagnosis was assigned to any
child with positive TST and QFT-G-IT and no clinical or
radiographic evidence of active TB.[39] Probable LTBI diagnosis
was assigned to any child with positive TST or QFT-G-IT and no
clinical or radiographic evidence of active TB.[39] Cases of active
TB were defined according to 2 categories: definite TB, children
with Mycobacterium tuberculosis cultured or detected by
microscopy or molecular methods from sputum or gastric
aspirate culture; probable TB: absence of microbiological
confirmation but presence of all of the following criteria (also
taking into account the origin of the child): clinical symptoms and
signs of active TB, abnormal radiography and/or computed
tomography scan consistent with lung TB, and response to TB
therapy.[39]
2.6. “Children with special needs” definition
As previously reported,[42–44] children were classified as having a
“special need” in case of:
(1) diagnosis of psychological or health problems, or a
documented condition that may lead to future problems;
(2) age ≥7 years; and
(3) siblings.
2.7. Statistical analysis
Data were reported as median and interquartile range (IQR) or
absolute numbers and percentages. All continuous variables were
not normally distributed thus the nonparametric Mann–Whitney
test was used to compare groups. Fisher exact test, Chi-square
test or Chi-square for trend tests were used to compare
categorical variables, as appropriate. Univariable and multivari-
able logistic regression analyses were performed to investigate the
association between presumed risk factors and intestinal
parasitosis, or a positive result of QFT-G-IT, a positive result
of TST, and discordant TST+/QFT-G-IT results. All statistical
analyses were carried out using the SPSS (Statistical Package of
Social Sciences, Chicago, IL) for Windows software program
version 19.0. A P value<0.05 was considered significant.
3. Results
3.1. Characteristics of the study population
Overall, 1612 children have been included in the study. Median
age at first evaluation was 5.3 years (IQR: 3.0–7.9); 961 (59.6%)
were males. Most of the children came from a European country
(685/1612; 42.5%) and, among them, 436 out of 685 (63.4%)
from Russia. Among extra-European countries, IAC most
frequently originated from Ethiopia (157/1612; 9.7%),
Colombia (122/1612; 7.6%), India (98/1612; 6.1%), and Brazil
(87/1612; 5.4%) (Table 1).
During the study period we did not observe substantial
fluctuations in the distribution of the different origins (x2 for
trend 2.565, P=0.11 for African; x2 for trend 0.84, P=0.35 for
American; x2 for trend 0.68 P=0.40 for Asian; and x2 for trend
1.26, P=0.26 for European adoptions), with the exception of a
significant reduction in the proportion of children coming from
Asia in 2011 to 2013 (with homogeneous increase of the
adoptions from other continents) with a successive increase in
2014 and 2015. Also, a significant decrease in IAC originating
from Africa was observed: the highest proportion was reached in
2013 (54/229; 23.6%) and decreased in 2014 (40/225; 15.7%)
and in 2015 (15/198; 7,6%) (x2 for trend 5.04, P=0.02). The
characteristics of the study children, classified according to their
country of origin, are summarized in Table 2. Children coming
from America were older at the time of adoption (median age 7.4
years; IQR: 5.1–9.0) than the children of the other groups
(median age 4.7 years; IQR: 2.7–7.2.0; P<0.0001), while
African children were the youngest (median age 3.9 years, IQR:
2.0–6.0) (P<0.0001).
Five hundred thirty-eight children out of 1612 (33.4%) were
≥7 years old. Five hundred seventeen children were adopted with
siblings (517/1612; 32.1%). In particular, 454/517 (87.8%;
28.2% of the total population) were adopted in couples, while
63/517 (12.2%; 3.91% of the total population) were adopted in
groups of 3 siblings. Interestingly, 123/1612 (7.6%) children had
medical conditions included in the special needs definition.[42–44]
Among them, 56/123 (45.5%) originated from Russia and 21/
123 (17.1%) from China. A substantial rate of children with cleft
lip and palate was observed among Chinese children (13/18 cleft
lip and palate diagnoses; 31.7% of all the adoptions fromChina),
while the majority of children with FASD, major congenital heart
disease, genetic syndromes and neurological disorders came from
Russia: 10/15 (66.7%) children with congenital heart disease, 22/
25 (88%) children with FASD, 4/7 (47.14%) children with
genetic disorders, and 13/27 (48.15%) children with neurological
disorders (2.3%, 5%, 0.9%, and 3% of all the adoptions from
Russia, respectively).
One percent of children (20/1612; 1.2%) displayed precocious
puberty, 18/20 (90.0%) being females. The majority of these girls
came from South America (8/18; 44.0%).
3.2. Infectious diseases prevalence
The most frequent cutaneous infections were Molluscum
contagiosum (42; 2.6%) and Tinea capitis (37; 2.3%). Viral
hepatitizes were rarely observed (HBV: 13 children, 0.8%; HCV:
1 child, 0.1%; HAV: 6 children, 0.4%) (Table 3).
No child was HIV-infected. Two children (0.1%) (1 South
American and 1 European) were known to be born to an HIV-
infected mother. Two Asiatic, 1 African, and 1 European child (4/
1612; 0.2%) had positive TPHA antibodies forT pallidum, with 2
of them also displaying positive VDRL-RPR, requiring treatment
with penicillin for probable congenital syphilis (Table 3). Almost
one-quarter of children 372/1612 (23.1%) presented with a
parasitic infection. Asian (82/291, 28.2%; x2=5.20;P=0.02) and
African (75/286, 26.2%; x2=1.93; P=0.16) children displayed
higher rates than the remaining ones. More than 10% of children
were positive for G lamblia (11.7%) and/or T canis (11.7%)
infection. Thirty-three children (2.1%) had more than 1 parasitic
infection. In particular, 29/1612 (1.8%) children had 2 parasitic
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infections (3.8% and 2.1% of the Asian and African adoptions,
respectively); and4/1612had3 simultaneousparasitic infections (2
European, 1 African, and 1 American children).
Univariable and multivariable analyses were performed to
evaluate possible predictors of intestinal parasitosis (Table 4).
No significant, independent higher risk for parasitosis was
evidenced considering age, sex, the interval between their
arrival in Italy and their first clinical evaluation (< or ≥3
months), continent of origin, TB infection diagnosis, and QFT-
G-IT (Table 4).
Table 1
Internationally adopted children classified according to their country of origin.
Continent Country Children, n
Adoptions from the same
continent of origin, %
Total study
group, %
Europe 685/1612 (42.5%) Russia 436 63.4 27
Ukraine 79 11.5 4.9
Hungary 44 6.4 2.7
Albania 6 0.9 0.4
Belarus 2 0.3 0.1
Bulgaria 51 7.4 3.2
Kosovo 1 0.1 0.1
Latvia 2 0.3 0.1
Lithuania 15 2.2 0.9
Moldova 6 0.9 0.4
Poland 32 4.7 2.0
Czech Republic 2 0.3 0.1
Romania 6 0.9 0.4
Slovakia 3 0.4 0.2
Asia 291/1612 (18.1%) Armenia 7 2.4 0.4
Bangladesh 1 0.3 0.1
China 41 14.1 2.5
Philippines 24 8.2 1.5
India 98 33.7 6.1
Kazakhstan 2 0.7 0.1
Nepal 8 2.7 0.5
Sri Lanka 5 1.7 0.3
Taiwan 1 0.3 0.1
Thailand 3 1.0 0.2
Vietnam 80 27.5 5.0
Cambodia 21 7.2 1.3
Africa 286/1612 (17.8%) Benin 4 1.4 0.2
Burkina Faso 28 9.8 1.7
Camerun 1 0.3 0.1
Cape Verde 1 0.3 0.1
Congo 59 20.6 3.7
Ivory Coast 1 0.3 0.1
Egypt 1 0.3 0.1
Eritrea 2 0.7 0.1
Ethiopia 157 54.7 9.7
Gambia 2 0.7 0.1
Guinea Bissau 2 0.7 0.1
Guinea 1 0.3 0.1
Kenya 4 1.4 0.2
Mali 13 4.5 0.8
Senegal 7 2.4 0.4
Somalia 1 0.3 0.1
Tanzania 1 0.3 0.1
Zambia 1 0.3 0.1
America 350/1612 (21.7%) Bolivia 12 3.4 0.7
Brazil 87 24.9 5.4
Chile 73 20.6 4.5
Colombia 122 35 7.6
Peru 40 11.5 2.5
Dominican Republic 1 0.3 0.1
Salvador 1 0.3 0.1
United States 1 0.3 0.1
Nicaragua 1 0.3 0.1
Mexico 1 0.3 0.1
Costa Rica 11 3.2 0.7
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3.3. Tuberculosis
In the study group, 1355/1612 (84.1%) children were screened
for TB. Active TB was diagnosed in 4/1355 (0.3%); 1129 out of
1355 children (83.3%) were classified as not TB infected. Latent
TB infection was diagnosed in 222/1355 (16.4%) children, with
higher prevalence in the American group (53/258; 20.5%; x2=
4.02; P=0.04) and European group (86/579; 14.8%; x2=1.73;
P=0.19). In particular, 50/222 (22.5%) were Confirmed Latent
TB, while 172/222 (77.5%) were Probable Latent TB cases.
Of note, only 51/1355 (3.7%) children had concordant
positive TST and QFT-G-IT results; while 154/1355 (11.4%)
had positive TST and negative QFT-G-IT and 18/1355 (1.3%)
had negative TST and positive QFT-G-IT (Table 5). No
indeterminate QFT-G-IT result was recorded. Eighty-three out
of 154 children (53.9%) with discordant TST+/QFT-G-IT
results came from Eastern Europe. Active TB was diagnosed in 2
children aged <5 and in 2 children aged ≥5. Prevalence of latent
TB was similar in the 2 subgroups (12.5% vs 14.8%; P=1.75;
x2=0.19). We observed a higher frequency (97/732; 13.25% vs
57/623; 9.15%) of positive TST and negative QFT-G-IT
discordant results in children aged ≥ 5 versus children aged
<5 (P=0.01; x2=5.62) and a higher proportion of BCG-
vaccinated children in the group ≥5 years versus <5 years (612/
732; 83.61% vs 418/623; 67.09%; P0.0001; x2=50.33).
Univariable and multivariable analyses were performed to
evaluate possible predictors of discordant results (positive TST
and negative QFT-G-IT; Table 6). A significant higher risk for
TST+/QFT-G-IT was related to BCG vaccination (adjusted
odds ratio [aOR]: 2.184 [1.26–3.79]; P=0.006) and age ≥5
(aOR: 1.49 [1.06–2.11]; P=0.02) (Table 6).
At univariable and multivariable logistic regression analyses
the only factor significantly associated with a positive TST result
Table 2
Characteristics of the study children, classified according to country of origin.
Characteristics Europe Asia Africa America Total
Population, n (%) 685 (42.5) 291 (18.1) 286 (17.8) 350 (21.7) 1612
Median age, y (IQR) 5.4 (3.4–8.1) 3.8 (1.6–7.0) 3.9 (2.0–6.0) 7.4 (5.1–9.0) 5.3 (3.0–7.9)
Females, n (%) 231 (33.7) 132 (45.4) 126 (44.0) 163 (46.6) 651 (40.4)
Males, n (%) 454 (66.3) 159 (54.6) 161 (56.1) 187 (53.4) 961 (59.6)
Days spent in Italy between date of arrival and
date of evaluation, median (IQR)
84 (53–173) 72.5 (39–153) 71.5 (41–236) 92 (60–153) 82 (50–164)
Cleft lip and palate, n (%) 3 (0.4) 14 (4.8) 0 (0.0) 1 (0.3) 18 (1.1)
Congenital heart disease, n (%) 11 (1.6) 2 (0.7) 0 (0.0) 2 (0.6) 15 (0.93)
Gastroschisis, n (%) 0 (0) 1 (0.3) 0 (0) 0 (0) 1 (0.1)
Fetal-alcohol spectrum disorders, n (%) 23 (3.4) 1 (0.34) 0 (0.0) 1 (0.3) 25 (1.6)
Neurological disorders, n (%) 17 (2.5) 6 (2.0) 0 (0.0) 4 (1.1) 27 (1.6)
Genetic disorders 4 (0.6) 3 (1.0) 0 (0.0) 0 (0.0) 7 (0.4)
Precocious puberty, n (%)
Males 0/454 (0.0) 1/159 (0.6) 0/161 (0.0) 1/187 (0.5) 2/961 (0.2)
Females 3/231 (1.3) 4/132 (3.0) 3/126 (2.4) 8/162 (4.9) 18/651 (2.8)
Renal defects, n (%) 3 (0.4) 0 (0.0) 0 (0.0) 1 (0.3) 4 (0.2)
Medical conditions included in the “special
needs” definition, n (%)
73 (10.6) 30 (10.3) 6 (2.1) 14 (4.0) 123 (7.6)
IQR = interquartile range.
Table 3
Infectious diseases prevalence in the study group (n=1612), according to continent of origin.
Infectious diseases, n (%) Europe Asia Africa America Total
HBV, n (%) 2 (0.3) 6 (2.1) 5 (1.7) 0 (0.0) 13 (0.8)
HCV, n (%) 0 (0.0) 1 (0.3) 0 (0.0) 0 (0.0) 1 (0.1)
HAV, n (%) 4 (0.6) 1 (0.3) 1 (0.3) 0 (0.0) 6 (0.4)
HIV, n (%) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Syphilis, n (%) 1 (0.1) 2 (0.7) 1 (0.3) 0 (0.0) 4 (0.2)
Tinea capitis, n (%) 17 (2.5) 6 (2.1) 3 (1.0) 11 (3.2) 37 (2.3)
Molluscum contagiosum, n (%) 15 (2.2) 7 (2.4) 12 (4.2) 8 (2.3) 42 (2.6)
Scabies, n (%) 3 (0.4) 3 (1.0) 1 (0.3) 0 (0.0) 7 (0.4)
Children with at least 1 parasitic infection, n (%)
∗
140/685 (20.4) 82/291 (28.2) 75/286 (26.2) 75/350 (21.4) 372/1612 (23.1)
Giardia lamblia, n (%) 65/685 (9.5) 47/291 (16.2) 33/286 (11.5) 44/350 (12.6) 189/1612 (11.7)
Toxocara canis, n (%) 82/685 (12.0) 30/291 (10.3) 35/286 (12.2) 42/350 (12) 189/1612 (11.7)
Other parasites, n (%)† 12/685 (1.8) 5/291 (1.7) 10/286 (3.5) 6/350 (1.7) 33/1612 (2.0)
Children with active TB, n (%) 0/579 (0.0) 2/254 (0.8) 2/264 (0.7) 0/258 (0.0) 4/1355 (0.3)
Children with probable latent TB (positive
TST or QFT-G), n (%)
66/579 (11.4) 31/254 (12.2) 34/264 (12.8) 41/258 (15.9) 172/1355 (12.7)
Children with confirmed latent TB (positive TST
and QFT-G), n (%)
20/579 (3.4) 11/254 (4.3) 7/264 (2.6) 12/258 (4.6) 50/1355 (3.7)
HAV= hepatitis A virus, HBV = hepatitis B virus, HCV = hepatitis C virus, HIV = human immunodeficiency virus types 1–2, QFT-G = QuantiFERON TB Gold In-tube, TB= tuberculosis, TST = tuberculin skin test.
∗
Any pathogen parasite infection included.
† Any pathogen parasite different from Giardia lamblia and Toxocara canis included.
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was previous vaccination with BCG (aOR 1.56 [95% confidence
interval 1.01–2.40]; P=0.04). On the contrary, the only factor
associated with a positive QFT result was the lack of a previous
BCG vaccination (aOR 0.47 [0.24–0.90]; P=0.023).
3.4. Immunization status
Vaccine documentation was available in 743/1612 (46.1%) cases
for tetanus and diphtheria, 655/1612 (40.6%) cases for HBV,
668/1612 (41.4%) for measles, and 628/1612 (38.9%) for
rubella, and was most frequently available in children originating
from Europe. In most children, specific serological tests versus
tetanus (1337/1612; 82.1%), diphtheria (170/1612; 10.5%),
HBV (1140/1612; 82.9%), rubella (1248/1612; 77.4%), and
measles (1243/1612; 77.1%) were performed for evaluating
protective or nonprotective antibody titer. A serological test for
mumps was performed only in a few cases (25/1612; 1.5%).
In particular, we observed that 15.7% children did not have a
protective serology for tetanus (208/1323); 26.4% children were
not protected for diphtheria (45/170), and 35.1% for HBV (469/
1337). A quarter of the children (25.9%, 322/1243) were not
protected for measles, 32.8%were not protected for rubella (410/
1248), and 40% for mumps (10/25) (Fig. 1).
Serological tests showed a variable discrepancy between the
available documentation and test results. In particular, a
nonprotection was documented in 9.0% (67/743) of children
considering tetanus, 1.9% (14/743) considering diphtheria,
24.1% (158/655) for HBV, 16.6% (111/668) for measles, and
23.4% (147/628) for rubella.
4. Discussion
In the present study we evaluated a population of 1612 IAC
(median age 5.4 years, 59.6% males) screened in a tertiary care
children’s hospital at their arrival in Italy. More than 40% came
from a European country and, among them, 63.4% from Russia.
Among extra-European countries, IAC most frequently originat-
ed from Ethiopia, Colombia, India, and Brazil. No substantial
changes in the distribution of the different origins were observed
during the study period, except for a significant decrease in IAC
Table 4
Risk factors for parasitic infection.
n/N Univariate analysis, OR (95% CI); P Multivariate analysis, aOR (95% CI); P
Sex
Females 152/651 (23.3%) 1
Males 220/961 (22.9%) 0.97 (0.77–1.23); P=0.83
Age, y
<5 199/749 (26.6%) 1 1
≥5 173/863 (20.0%) 0.69 (0.55–0.87); P=0.002 0.79 (0.60–1.06); P=0.115
Time in Italy, mo
<3 142/1017 (14.0%) 1 1
≥3 18/274 (6.6%) 2.31 (1.38–3.84); P=0.001 1.08 (0.75–1.62); P=0.773
Eosinophil count
<1000/mL 341/1142 (23.6%) 1 1
≥1000/mL 23/62 (37.1%) 3.87 (1.86–8.04); P=0.0001 1.73 (0.90–3.23); P=0.102
Not tested 8/108 (7.4%) 7.37 (3.04–17.87); P<0.0001 2.33 (0.84–11.36); P=0.09
Tuberculosis infection (active and latent tuberculosis)
No 289/1129 (25.6%) 1
Yes 60/226 (26.5%) 0.95 (0.69–1.32); P=0.76
QFT-G-IT result
Negative 321/1274 (25.2%) 1 1
Positive 25/69 (36.2%) 3.15 (2.064.81); P<0.0001 1.34 (0.74–2.54); P=0.307
Not tested 26/269 (9.7%) 5.31 (2.81–10.03); P<0.0001 0.58 (0.37–1.97); P=0.632
Continent of origin
Europe 140/685 (20.4%) 1 1
Africa 75/286 (26.2%) 1.38 (0.99–1.90); P=0.052 1.18 (0.80–1.73); P=0.399
America 75/350 (21.4%) 1.07 (0.78–1.46); P=0.69 1.07 (0.86–2.22); P=0.717
Asia 82/291 (28.2%) 1.53 (1.11–2.09); P=0.009 1.40 (0.96–2.01); P=0.082
aOR = adjusted odds ratio, CI = confidence interval, OR = odds ratio, QFT-G-IT = QuantiFERON TB Gold In-Tube.
Table 5
TST and QFT-G-IT test results in BCG vaccinated and nonvaccinated children.
Children
BCG-vaccinated (confirmed
with documentation or scar), n (%)
Non-BCG vaccinated/scar
not present, n (%) P
TST+/QFT-G+ 51 38/51 (76.0%) 12/51 (24.0%) 0.29 (x2=1.12)
TST+/QFT-G-IT 154 139/154 (90.3%) 15/154 (9.7%) 0.003 (x2=8.52)
TST/QFT-G+ 18 13/18 (72.2%) 5 (27.8%) 0.29 (x2=1.09)
TST/QFT-G or not performed 1129 914/1129 (81.0%) 215/1129 (19%) 0.12 (x2=2.39)
TST not performed and QFT-G 9 7/9 (77.8%) 2/9 (22.2%) 0.76 (x2=0.09)
TST and QFT-G not performed 257 8/257 (3.1%) 249/257 (96.9%)
BCG = Bacille de Calmette-Guérin, QFT-G-IT = QuantiFERON-TB-Gold In-Tube, TST = tuberculin skin test.
Sollai et al. Medicine (2017) 96:12 Medicine
6
originating from Africa in the last 2 years (x2 for trend 5.04, P=
0.02). This phenomenon could be related to the decision of the
Democratic Republic of Congo to suspend international
adoptions on September 2013,[45] a measure that was eliminated
in January 2016.[46]
The high prevalence (7.6%) of medical conditions included in
the special needs definition[42–44] is to be underlined. Almost 50%
of these children originated from Russia, 17.1% from China. In
particular, the majority of children with FASD (88%), major
congenital heart disease (66.7%), genetic syndromes (47.14%),
and neurological disorders (48.15%) came from Russia, whereas
a substantial rate of children with cleft lip and palate was Chinese
(72.22%). One percent of children displayed precocious puberty,
90% being females, and 44% of the cases originating from South
America. Infectious diseases were common: 23.1% of the
children had at least 1 parasitic infection, mainly by T canis
andG lamblia (more than 10% each), while other parasites were
involved in 2% of the cases. Also, cases of multiple (2 or 3)
simultaneous parasitosis were recorded (33/1612, 2.0%).
Viral hepatitizes were rarely observed (<1%). No child was
HIV-infected, 4 children had positive TPHA antibodies for
T pallidum. All these prevalence rates are similar or lower
compared to available studies conducted in Europe and
Italy.[2,13,16] In particular, parasitic intestinal infections were
reported in 8% to 38% of cases.[2,10,13,23,33,34,36] In a recent
Italian study, parasitological investigation of feces was found to
be positive up to 42.7% children.[16] All these studies have
described G lamblia, Hymenolepis nana, Entamoeba hystolitica,
and Strongyloides stercoralis as the most frequent parasitoses,
whereas in our cohort T canis was the most frequent parasitic
pathogen besides G lamblia. This could be possibly related to a
lack of T canis serology in the large majority of the
studies.[2,13,16,32] It should be also taken into account that the
presence of T canis serology (IgG) does not make a distinction
possible between current or past infections, and these data only
represent an evaluation of seroprevalence. On the other hand, the
high prevalence of a positive ova and parasite examination could
be related to the high sensitivity reached by the test when
performed on 3 stool specimens. In fact, authors have previously
confirmed that in high-risk groups of children such as IAC,
gastrointestinal symptoms are not predictive of pathogen
recovery, and multiple stool specimen evaluations make an
increase in pathogen identification possible.[23] Staat and
colleagues, in their observational study on 1042 IAC, observed
that parasite identification was significantly associated with
increasing age, but not with malnutrition and gastrointestinal
symptoms. Overall, the yield of 1 stool specimen was 79% with
pathogen recovery significantly increasing for 2 (92%) and 3
Table 6
Risk factors for positive tuberculin skin test and negative QuantiFERON-TB-Gold In-Tube results.
n/N=1355 Univariate analysis, OR (95% CI); P Multivariate analysis, OR (95% CI); P
Sex
Females 66/544 (12.1%) 1
Males 88/811 (10.9%) 1.13 (0.80–1.59); P=0.46
BCG/scar
No 15/247 (6.1%) 1 1
Yes 139/1108 (12.5%) 2.22 (1.28–3.85); P=0.005 2.184 (1.26–3.79); P=0.006
Age, y
<5 57/623 (9.1%) 1 1
≥5 97/732 (13.3%) 1.52 (1.07–2.14); P=0.02 1.49 (1.06–2.11); P=0.02
Time in Italy before evaluation, mo
<3 81/788 (10.3%) 1
≥3 28/254 (11.0%) 1.08 (0.68–1.70); P=0.74
Eosinophil count
< 1000/mL 147/1287 (11.4%) 1
≥ 1000/mL 6/50 (12.0%) 1.06 (0.44–2.52); P=0.90
Not tested 1/18 (5.6%) 0.46 (0.06–3.45); P=0.45
Parasite infection
No 120/1006 (11.9%) 1
Yes 34/349 (9.7%) 0.80 (0.53–1.19); P=0.27
Continent of origin
Europe
Africa 65/579 (11.2%) 1
America 20/238 (8.4%) 0.72 (0.43–1.22); P=0.23
Asia 1.32 (0.87–2.00); P=0.19
42/294 (14.3%) 0.98 (0.61–1.58); P=0.95
27/244 (11.1%)
BCG = Bacille de Calmette-Guérin, CI = confidence interval, OR = odds ratio.
Figure 1. Serologies for the vaccine-preventable infectious diseases. HBV =
hepatitis B virus.
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(100%) specimens, respectively (P<0.0001). Pathogen identifi-
cation also significantly increased with the evaluation of
additional stool specimens for children with and without
gastrointestinal symptoms.[23]
Differently from our population, in which a prevalence of
around 2%was observed for easily treatable cutaneous infections
by M contagiosum and T capitis, a prevalence of cutaneous
infections in available studies was reported between 22% and
35%.[2,10,13,16,23,33,34,36]
Active TB was diagnosed in 4 children. Nevertheless, latent TB
infection (defined with a positive result of TST and QFT or with a
positive result either of TST or QFT-G-IT) was diagnosed in
16.4% of the children. This is in line with the 5% to 26%
prevalence reported in available literature.[4,27,30,47–49] In the
absence of a recognized gold standard, diagnosis of latent TB in
children is challenging. It is possible that in the IAC population
LTBImay be overestimated in those cases with a positive TST and
a negative QFT-G-IT result because of poor TST specificity, due
to a cross-reaction with BCG vaccination, booster effect of
previous multiple TST tests, and possible nontuberculous
mycobacterial infections. In fact, only 3.7% children had
concordant TST+/QFT-G-IT+ results; whereas 11.4% had TST
+/QFT-G-IT and 1.3% had TST/QFT-G-IT+. Similar data
were recently reported by Howley and colleagues in 2520
immigrant children screened for latent TB, but with a higher
proportion of TST+/QFT-G-IT+: 4.4% were TST+/QFT+,
21.9% were TST+/QFT, and 1.2% were TST/QFT+.[48]
The authors also reported a significant association with older age
and with the presence of TB in at least 1 immigrating family
member.[48] In our study, we also observed a higher frequency
(13.25% vs 9.15%) of TST+/QFT-G-IT discordant results in
children ≥5 years: this could be related to more prolonged
exposure to TB cases in the country of origin (in the large
majority of these countries TB is endemic) and to routinely
repeated TST in orphanages. In fact, the large majority of
children with discordant TST+/QFT-G-IT results came from
eastern-Europe (83/154; 53.9%), where children reside in
orphanages and undergo to repeated TST, possibly leading to
an increased risk of a positive result. Moreover, we observed in
the same population a higher proportion of BCG-vaccinated
children versus in those ages <5 (P  0.0001). A significantly
higher and independent risk of TST+/QFT-G-IT with BCG
vaccination and age ≥5 years was confirmed in a multivariable
analysis (aOR: 2.184 [1.26–3.79]; P=0.006) and (aOR: 1.49
[1.06–2.11]; P=0.02). Association between BCG and positive
TST results in children was widely confirmed, in particular in a
large meta-analysis, on 117,507 subjects.[50–52]
Interferon-gamma-release assays (IGRA) performance in pedi-
atric populations is still under debate and caution is recommended
for their use and interpretation in young children.[53–57] For its
advantage of not being influenced by BCG, several authors have
studied and confirmed the importance of QFT-G-IT especially in
BCG-vaccinated children, but on the other hand, children under
the age of 2 and nonvaccinated children may display negative
results.[53–57] In a systematic review and meta-analysis that we
published in 2014, IGRAs showed good promise for improvingTB
diagnosis only in immunocompetent children >5 years, in a high-
income setting. Even in these subjects, however, IGRAs sensitivity
was 67% to 86%, indicating that neither test may rule out nor
confirm the certainty of diagnosis and, similarly to the TST,
interpretation of results may be difficult.[58] It has been described
that IGRA performance is influenced by the child’s immunologic
status, which, in turn, may be impaired by several conditions
commonly observed in low-income countries, such as malnutri-
tion,HIV infection, andhelminthiasis.[59–64]One limit of our study
is that we were not able to consider the subjects’ nutritional status.
Moreover, no helminthic infection was described in our popula-
tion, with the exception of 1 case of Tenia solium infection.
Available data on association between parasitic infections and
TST and QFT-G-IT results are poor[34,65]: Wassie and colleagues
screened 245 healthy school children from Addis Abeba, a TB-
endemic region, with TST andQFT-G-IT. Although concordance
between the tests was generally fair (90%), there was a subset of
children who had positive QFT-G-IT with negative TST and a
strong association with the presence of parasites in the stool of
these patients.[65] Piñeiro-Pérez et al did not found differences in
TST results among 1074 infected and noninfected children.[34] In
our univariable and multivariable analyses, we did not find an
association between parasite infection and positive result of TST
or of QFT-G-IT, nor with eosinophilia. However, only 1 case of
helminthic infection by T solium was found.
In our univariable and multivariable logistic regression
analyses, the only factor associated with a positive QFT results
was the lack of previous BCG vaccination: this phenomenon
could be explained by protection guaranteed by BCG versus TB
infection, as previously reported.[51,52] Indeed, as it is demon-
strated that BCG vaccination provides a good level of protection
against tuberculousmeningitis and disseminated forms, and a fair
level of protection against pulmonary disease, the possibility for
vaccinated children to be TB infected was widely observed and
described.[51,52]
Concerning vaccinations, the majority of the children under-
went specific serologic tests to evaluate protective or non-
protective antibody titer versus tetanus (82.1%), HBV (82.9%),
rubella (77.4%), and measles (77.1%), displaying a non-
protective serology in 15.7%, 35.1%, 32.8%, and 25.9%
respectively. All these serologies were performed with CLIAs
which in previous studies displayed high sensitivity and specificity
(≥97.6% and ≥96.6%, respectively, for all the serologies).[66–70]
These data are similar to those recently published,[13,15,17,19]
confirming that IAC should be tested rapidly for their
immunization status on arrival in the adopting country, because
they are not protected in a sufficient way against vaccine-
preventable diseases. Moreover, preadoptive immunization
records are often lacking and scarcely reliable[13,15,17,19]: indeed,
in our population vaccine documentation was available in only
38.9% to 46.1% of the cases (mostly in European children), with
a variable discrepancy between available documentation and test
results (ranging from 9% for tetanus and 24.1% for HBV). Some
authors reported that in a population of 562 IAC the number of
doses recorded was the best predictor of protective antibody
titer,[71] but in our study, 52/616 (8.4%) children with ≥3 doses
of tetanus vaccine had a nonprotective antibody titer.
Considering the costs related to all the performed serologies,
and the cost of revaccinating, the recommendation of empirically
revaccinating all internationally adopted children could be
reasonable. Clearly, a cost analysis was not one of the purposes
of our study; however, our results could encourage further studies
focusing on this specific topic that could be useful to optimize
present screening strategies.
Our cross-sectional study had some limitations. Dividing the
population into subgroups for analyses and comparisons led to
limited subsets of patients. Furthermore, during the 7-year study
period some investigations included in the screening protocol
changed, and some tests were not performed in the whole
population: in fact, the large majority of the children referred to
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our Center and included in the study were evaluated as per
protocol, but for some variables we had some missing
information possibly due to the physicians’ incomplete adherence
to the screening protocol or to an incomplete collection of data in
medical records. Indeed, it must be considered that our Center
was able to visit only a part of all the adopted children arriving in
our region, as some parents (despite the recommendation to see a
doctor for all adopted children, regardless of their country of
origin) may have consulted their family physician or no one at all.
5. Conclusions
Our data underline the importance of a rapid, careful, and
complete screening in IAC. Clinical problems have been observed
frequently, ranging from congenital malformations, complex
infectious diseases, as TB infection (16.7%) and parasitosis
(23.1%), to nonsevere and easily treatable infections, as M
contagiosum and fungal skin infections. Notably, 39.14%
children had at least 1 infectious disease, with a total of 743
infectious diseases diagnoses in 631 children. It is important to
consider the vaccine documentation and screening of the IAC in
order to update immunizations. Moreover, according to our
results, the diagnosis of latent TB infection is particularly
difficult, due to the high rate of discordant TST/QFT-G results.
QFT-G-IT results may be more reliable in children over the age of
5, suggesting the utility in this subset of children of a “wait and
see” approach, monitoring the child with QFT-G-IT, to avoid
overtreatment.
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